• Mashup Score: 0

    Implementing sex-specific troponin thresholds for diagnosing acute MI did not significantly affect outcomes for transgender patients, researchers reported.“Diagnosing acute MI requires the detection of cardiac troponin above the 99th percentile upper reference limit,” Ming-Sum Lee, MD, PhD, FACC, FAHA, FASE, program director of cardiology fellowship at Kaiser Permanente Los Angeles

    Tweet Tweets with this article
    • Implementing sex-specific #troponin thresholds for diagnosing acute MI did not significantly affect outcomes for #transgender patients @KP_LAMC #Cardiotwitter https://t.co/HVNVehLuWi

  • Mashup Score: 0

    Commentary on: Dawson LP, Nehme E, Nehme Z, Zomer E, Bloom J, Cox S, Anderson D, Stephenson M, Ball J, Zhou J, Lefkovits J, Taylor AJ, Horrigan M, Chew DP, Kaye D, Cullen L, Mihalopoulos C, Smith K, Stub D. Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment. JAMA Intern Med . 2023 Mar 1;183(3):203-211. doi: 10.1001/jamainternmed.2022.6409. Acute chest pain is one of the most common reasons for emergency system activation and transfer to the emergency department (ED).1 Only a minority of …

    Tweet Tweets with this article
    • Are we ready for #prehospital #troponin testing by #paramedics ? @cvrints https://t.co/fc0Ru00nfT

  • Mashup Score: 1

    The FDA announced that it has designated a recall of blood tests for cardiac troponin shown to produce false negatives for MI as class I, the most serious kind.On May 25, Quidel Cardiovascular Inc. recalled its cardiac panels (Quidel Triage Cardiac Panel; Quidel Triage Cardiac Panel, Troponin I; and Quidel Triage Cardiac Panel, CK-MB and Troponin I) after it received reports of inaccurate tests

    Tweet Tweets with this article
    • #ICYMI: The #FDA has designated a recall of certain #blood tests for cardiac #troponin due to the risk for false negative or falsely low levels, which can result in missed or delayed #MI diagnoses. https://t.co/wmKEyu4Qlz

  • Mashup Score: 1

    The FDA announced that it has designated a recall of blood tests for cardiac troponin shown to produce false negatives for MI as class I, the most serious kind.On May 25, Quidel Cardiovascular Inc. recalled its cardiac panels (Quidel Triage Cardiac Panel; Quidel Triage Cardiac Panel, Troponin I; and Quidel Triage Cardiac Panel, CK-MB and Troponin I) after it received reports of inaccurate tests

    Tweet Tweets with this article
    • #FDA designates recall of #troponin tests producing false-negative #heartattack results as class I https://t.co/oRPEg16Brt @US_FDA @FDArecalls #Cardiotwitter #Cardiology